Industry
Japan's Daiichi Sankyo to acquire US biopharma Ambit Biosciences
Japanese drugmaker Daiichi Sankyo Co Ltd (4568.T) has agreed to acquire U.S. biopharmaceutical company Ambit Biosciences Corp (AMBI.O) in a deal valued up to $410 million as it looks to build its presence in oncology, the companies said.
Brussels to accuse Apple over illegal Irish tax deals: FT
The European Commission will accuse Apple Inc (AAPL.O) of benefiting from illicit state aid in Ireland, based on preliminary findings of an investigation into tax deals, the Financial Times reported citing people familiar with the matter.
Instagram reportedly blocked in China amid Hong Kong protests
Instagram, the popular photo-sharing service owned by Facebook Inc (FB.O), has been blocked in China, according to numerous reports, including from Hong Kong-based reporters with the New York Times.
Dollar hits four-year high, Asian stocks on edge as HK seethes
The dollar hit a four-year peak against a basket of currencies in early Asian trade on Monday, bolstering Japanese shares, but other Asian shares shrugged off Friday's Wall Street rebound in the face of political unrest in Hong Kong.